Petauri™ Acquires Artia Solutions, Expanding Market Access Expertise in Medicaid

Rapidly growing pharmaceutical services platform adds Medicaid access consulting to its core capabilities

 NASHVILLE, Tenn (July 15, 2025) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the acquisition of Artia Solutions, a premier consultancy specializing in Medicaid market access and the related dynamic regulatory environment. The combination strengthens Petauri’s capabilities in helping clients navigate complex reimbursement landscapes and expands its footprint in the public payer space.

“We are thrilled to welcome Artia Solutions to Petauri,” said Dan Renick, CEO of Petauri. “Artia’s deep expertise in state Medicaid programs and policy perfectly complements Petauri’s mission to drive access and impact for innovative therapies. Together, we are better positioned to support our clients across every facet of market access.”

Founded in 2005 by George Kitchens, RPh, Artia Solutions has built a reputation for helping manufacturers effectively engage with Medicaid decision-makers. The firm’s team brings decades of experience in public payer policy, supplemental rebate negotiations, and market access strategy.

“Our team is excited to join forces with Petauri,” said George Kitchens, Co-President and Founder of Artia Solutions. “We are so grateful for the opportunity to share in Petauri’s commitment to delivering tailored, impactful strategies for clients. By coming together, we can offer an even broader range of services and drive greater value for the manufacturers we serve.”

The integration of Artia Solutions will enhance Petauri’s ability to deliver seamless support and integrate deep subject-matter expertise across commercial and government channels, reinforcing its commitment to being a true end-to-end partner for life sciences companies.

“This acquisition marks a significant milestone in Artia’s 20-year journey,” said Matt Dull, Co-President of Artia Solutions. “We’ve always believed in the power of strategic, data-driven consulting to improve access to life-saving therapies. By aligning with Petauri, we can now bring our Medicaid expertise to a broader platform and help even more clients succeed in today’s evolving healthcare landscape.”

The acquisition reflects Petauri’s broader strategy of building a fully integrated platform that supports biopharmaceutical companies from development through commercialization, with a relentless focus on access, value, and outcomes.

About Petauri

Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in life sciences, health systems, scientific communications, and market access.

Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, Formulary Insights, and Artia Solutions, all now Powered by Petauri™. The legacy organizations now comprise Petauri’s 6 business units—Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, Petauri MAx, and Artia Solutions. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances.

From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.

Media Contact:

Liz Gulino
Petauri
Liz.Gulino@petauri.com
973-476-1751